InsidersTradesSigma
Follow the 久光製薬株式会社 stock price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are listed on JP JP, under the oversight of EDINET (Japan FSA). Market capitalisation: €37,506.9bn. The latest transaction was disclosed on 30 April 2026 (Holding update). Among the most active insiders: TAIYO KOSAN CO.,INC.. All data is openly available.
Analysts rate 久光製薬株式会社 Buy (bullish), based on 11 analysts. Average price target: JP¥3,312.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
12 of 12 declarations
Kuwakou Pharmaceutical Co., Ltd. is a Japanese company specializing in the manufacture of pharmaceutical products, including medicines and medical devices. It is listed on the Tokyo Stock Exchange.